Market Research Report
Blood-Brain Barrier Technologies and Global Markets
|Published by||BCC Research||Product code||174964|
|Published||Content info||116 Pages
Delivery time: 1-2 business days
|Blood-Brain Barrier Technologies and Global Markets|
|Published: July 28, 2014||Content info: 116 Pages||
The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.
The scope of this study encompasses companies that develop technologies to enable the crossing of the BBB and drug development, in which a quality of the development is enabling the crossing of the BBB, where passage was previously impossible often due to size. BCC Research analyzes each technology, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next five years. Technological issues, including the latest trends, are discussed.
Kim Lawson is a graduate of Mount Holyoke College with a degree in English Literature. She acquired experience as a healthcare journalist, including working for John Wiley & Sons as a print reporter, before serving as a research analyst in a small market research firm that focused on pharmaceuticals and biotechnology in the Research Triangle Park area of North Carolina. Before joining that firm, Kim published two reports on emerging and established diagnostics and therapeutics for benign and cancerous breast disease.